Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Progression-free survival was longer and response rates were higher in patients with metastatic renal-cell cancer who received sunitinib than in those receiving interferon alfa ...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 5,691
- Institution
- Cleveland Clinic
External Links
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.